Skip to main content
SpringerLink
Log in

Effects of Preimplantation Processing on Bioprosthetic and Biologic Cardiac Valve Morphology

  • Chapter
Cardiac Reconstructions with Allograft Valves

Abstract

The evolution of cardiac valve substitutes for the management of valvular heart disease has been taking place for approximately a quarter-century. A heterogeneous group of components, including pyrolytic carbon, polymeric, and tissue-derived materials, have been configured into mechanical, polymeric, bioprosthetic, and biologic valve designs.1–11 For the purpose of this review, however, only tissue-derived xenograft and allograft cardiac Valves are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Sebening F, Klovekorn WP, Meisner H, Struck E (eds): Bioprosthetic Cardiac Valves. Munich: Deutsches Herzzentrum, München, 1979.

    Google Scholar 

  2. Lefrak EA, Starr A (eds): Cardiac Valve Prostheses. New York: Appleton-Century-Crofts, 1979.

    Google Scholar 

  3. Ionescu MI (ed): Tissue Heart Valves. London: Butterworth, 1979.

    Google Scholar 

  4. DeBakey ME: Advances in Cardiac Valves: Clinical Perspectives. New York: Yorke, 1983.

    Google Scholar 

  5. Cohn LH, Gallucci V (eds): Cardiac Bio-prostheses. New York: Yorke, 1982.

    Google Scholar 

  6. Morse D, Steiner RM, Fernandez I (eds): Guide to Prosthetic Cardiac Valves. New York: Springer-Verlag, 1985.

    Google Scholar 

  7. Bodnar E, Yacoub M (eds): Biologic and Bio-prosthetic Valves. New York: Yorke, 1986.

    Google Scholar 

  8. Bjork VO, Cullhed I, Lodin H: Aortic valve prosthesis (Teflon): two year follow-up. J Thorac Cardiovasc Surg 45: 635–644, 1963.

    PubMed  CAS  Google Scholar 

  9. Braunwald NS, Morrow AG: A late evaluation of flexible Teflon prostheses utilized for total aortic valve replacement: postoperative clinical, hemodynamic and pathologic assessments. J Thorac Cardiovasc Surg 49: 485–496, 1965.

    PubMed  CAS  Google Scholar 

  10. Wisman CB, Pierce WS, Donachy JH, et al: A polyurethane trileaflet cardiac valve prosthesis: in vitro and in vivo studies. Trans Am Soc Artif Intern Organs 28: 164–168, 1982.

    PubMed  CAS  Google Scholar 

  11. Hilbert SL, Ferrans VJ, Tomita Y, et al: Evaluation of explanted polyurethane trileaflet cardiac valve prostheses. J Thorac Cardiovasc Surg 94: 419–429, 1987.

    PubMed  CAS  Google Scholar 

  12. Gabbay S, Frater RWM: The unileaflet heart valve bioprosthesis: new concept. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 411–424.

    Google Scholar 

  13. Bodnar E, Bowden NL, Drury PJ, et al: Bicuspid mitral bioprosthesis. Thorax 36: 45–51, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Black MM, Drury PJ, Tindale WB, Lawford PV: The Sheffield bicuspid valve: concept, design and in vitro and in vivo assessment. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 709–717.

    Google Scholar 

  15. Zerbini EJ, Puig LB: Experience with dura-ma-ter allograft: long term results. In Sebening F, Klovekorn WP, Meisner H, Struck E (eds): Bioprosthetic Cardiac Valves. Munich: Deutsches Herzzentrum München, 1979, pp. 179–197.

    Google Scholar 

  16. Senning A: Fascia lata replacement of aortic valves. J Thorac Cardiovasc Surg 54: 465–470, 1967.

    PubMed  CAS  Google Scholar 

  17. Rodewald G, Akrami R, Bantea C, et al: Long-term follow-up of aortic valve replacement using fascia-lata-graft according to Ionescu. In Sebening F, Klovekorn WP, Meisner H, Struck E (eds): Bioprosthetic Cardiac Valves. Munich: Deutsches Herzzentrum München, 1979, pp. 161–177.

    Google Scholar 

  18. Petch M, Somerville J, Ross DN, et al: Replacement of the mitral valve with autologous fascia lata. Br Heart J 36: 177–181, 1974.

    Article  PubMed  CAS  Google Scholar 

  19. Bodnar E, Ross DN: Mode of failure in 226 explanted biologic and bioprosthetic valves. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 401–407.

    Google Scholar 

  20. Silver MD, Hudson REB, Trimble AS: Morpho-logic observations on heart valve prostheses made of fascia lata. J Thorac Cardiovasc Surg 70: 360–366, 1975.

    PubMed  CAS  Google Scholar 

  21. Woodroof EA: The chemistry and biology of aldehyde treated tissue heart valve xenografts. In Ionescu MI (ed): Tissue Heart Valves. London: Butterworth, 1979, pp. 347–362.

    Google Scholar 

  22. Cheung DT, Perelman N, Ko EC, Nimni ME: Mechanism of crosslinking of proteins by glutaraldehyde. III. Reaction with collagen in tissues. Connect Tissue Res 13: 109–115, 1985.

    Article  PubMed  CAS  Google Scholar 

  23. Cheung DT, Nimni ME: Mechanism of crosslinking of proteins by glutaraldehyde. II. Reaction with monomelic and polymeric collagen. Connect Tissue Res 10: 201–216, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Broom ND: Simultaneous morphologic and stress-strain studies of fibrous components in wet heart valve leaflet tissue. Connect Tissue Res 6: 37–50, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Broom N, Christie GW: The structure/function relationship of fresh and glutaraldehyde-fixed aortic valve leaflets. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 476–491.

    Google Scholar 

  26. Gavilanes JG, Gonzalez de Buitrago G, Lizarbe MA, et al: Stabilization of pericardial tissue by glutaraldehyde. Connect Tissue Res 13: 37–44, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Sade RM, Greene WB, Kurtz SM: Structural changes in a procine xenograft after implantation for 105 months. Am J Cardiol 44: 761–766, 1979.

    Article  PubMed  CAS  Google Scholar 

  28. O’Brien MF, Clarebrough JK: Heterograft aortic valve transplantatioin for human valve disease. Med J Aust 2: 228–230, 1966.

    PubMed  Google Scholar 

  29. O’Brien MF: Heterologous replacement of the aortic valve. In Ionescu MI, Ross DN, Woller GH (eds): Biological Tissue and Heart Valve Replacement. London: Butterworth, 1972, pp. 445–466.

    Google Scholar 

  30. Buch WS, Kosek JC, Angell WW, Shumway SE: Deterioration of formalin-treated aortic valve heterografts. J Thorac Cardiovasc Surg 60: 673–682, 1970.

    PubMed  CAS  Google Scholar 

  31. Dubiel WT, Johansson L, Willen R: Late changes in formalin-treated porchine aortic heterografts replacing human mitral valves. Scand J Thorac Cardiovasc Surg 9: 16–26, 1975.

    Google Scholar 

  32. Bortolotti V, Milano A, Mazzucco A, et al: Lon-gevity of the formaldehyde-preserved hancock porcine heterograft. J Thorac Cardiovasc Surg 84: 451–453, 1982.

    PubMed  CAS  Google Scholar 

  33. Ferrans VJ, Spray TL, Billingham ME, Roberts WC: Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves: transmission and scanning electron microscopic observation in 12 patients. Am J Cardiol 41: 1159–1184, 1978.

    Article  PubMed  CAS  Google Scholar 

  34. Yarbrough JW, Roberts WC, Reis RL: Structural alterations in tissue cardiac valves implanted in patients and in calves. J Thorac Cardiovasc Surg 65: 364–375, 1973.

    PubMed  CAS  Google Scholar 

  35. Broom ND, Thomson FJ: Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves: towards a more scientific basis. Thorax 34: 166–176, 1979.

    Article  PubMed  CAS  Google Scholar 

  36. Swanson WM, Clark RE: Dimensions and geo- metic relationships of the human aortic valve as a function of pressure. Circ Res 35: 871–882, 1974.

    PubMed  CAS  Google Scholar 

  37. Brewer RJ, Mentzer RM, Deck JD, et al: An in vivo study of the dimensional changes of the aortic valve leaflets during the cardiac cycle. J Thorac Cardiovasc Surg 74: 645–650, 1977.

    PubMed  CAS  Google Scholar 

  38. Deck JD, Thubrikar MJ, Schneider PJ, Nolan SP: Structure, stress and tissue repair in aortic valve leaflets. Cardiovasc Res 22: 7–16, 1988.

    Article  PubMed  CAS  Google Scholar 

  39. Broom ND: An in vitro study of mechanical fatigue in glutaraldehyde-treated procine aortic valve tissues. Biomaterials 1: 3–8, 1980.

    Article  PubMed  CAS  Google Scholar 

  40. Hilbert SL, Ferrans VJ, Swanson WM: Optical methods for the nondestructive evaluation of collagen morphology in bioprosthetic heart valves. J Biomed Mater Res 20:1411bioprosthetie1421,1986.

    Google Scholar 

  41. Zerbini E J, Puig LB: The dura mater allograft valve. In Ionescu MI (ed): Tissue Heart Valves. London: Butterworth, 1979, pp. 253–301.

    Google Scholar 

  42. Puig LB, Verginelli G, Iryia K, et al: Homologous dura mater cardiac valves: study of 533 surgical cases. J Thorac Cardiovasc Surg 69: 722–728, 1975.

    PubMed  CAS  Google Scholar 

  43. Centers for Disease Control: Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR 36: 49–50, 55, 1987.

    Google Scholar 

  44. Barnhart GR, Jones M, Ishihara T, et al: Degeneration and calcification of bioprosthetic cardiac valves: bioprosthetic tricuspid valve implantation in sheep. Am J Pathol 106: 136–139, 1982.

    PubMed  CAS  Google Scholar 

  45. Arbustini E, Jones M, Moses RD, et al: Modifi-cation by the Hancock T6 process of calcification of bioprosthetic cardiac valves implanted in sheep. Am J Cardiol 53: 1388–1396, 1984.

    Article  PubMed  CAS  Google Scholar 

  46. Jones M, Eidbo EE, Walters SM, et al: Effects of two types of preimplantation processes on calcification of bioprosthetic valves. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 451–459.

    Google Scholar 

  47. Fishbein MC, Levy RJ, Ferrans VJ, et al: Calcifi-cation of cardiac valve bioprostheses: biochemical, histologic and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg 83: 602–609, 1982.

    PubMed  CAS  Google Scholar 

  48. Schoen FJ, Levy RJ, Nelson AC, et al: Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 52: 523–532, 1985.

    PubMed  CAS  Google Scholar 

  49. Schoen FJ, Tsao JW, Levy RJ: Calcification of bovine pericardium used in cardiac valve bio-prostheses: implication for the mechanism of bioprosthetic tissue mineralization. Am J Pathol 123: 134–145, 1986.

    PubMed  CAS  Google Scholar 

  50. Thiene G, Arbustini E, Bortolotti V, et al: Pathologic substrates of porcine valve dysfunction. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 378–400.

    Google Scholar 

  51. Schoen FJ, Hobson CE: Anatomic analysis of removed prosthetic heart valves: causes of failure in 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 16: 549–559, 1985.

    Article  PubMed  CAS  Google Scholar 

  52. Schoen FJ, Kujovich JL, Levy RJ, St John Sutton M: Bioprosthetic valve failure. Cardiovasc Clin 18: 289–317, 1987.

    Google Scholar 

  53. Gallucci V, Bortolotti U, Milano A, et al: The Hancock porcine valve 15 years later: an analysis of 575 patients. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 91–97.

    Google Scholar 

  54. Milano A, Bortolotti V, Talenti E, et al: Calcific degeneration as the main course of porcine bioprosthetic valve failure. Am J Cardio 53: 1066–1070, 1984.

    Article  CAS  Google Scholar 

  55. Ferrans VJ, Boyce SW, Billingham ME, et al: Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 46: 721–734, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Valente M, Bortolotti U, Thiene G: Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 119: 12–21, 1985.

    PubMed  CAS  Google Scholar 

  57. Carpentier A, Lemaigre G, Robert L, et al: Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 58: 467–483, 1969.

    PubMed  CAS  Google Scholar 

  58. Dunn JM, Marmon L: Mechanisms of calcification of tissue valves. Cardiol Clin 3: 385–396, 1985.

    Google Scholar 

  59. Sanders SP, Levy RJ, Freed MD, et al: Use of Hancock porcine xenografts in children and adolescents. Am J Cardiol 46: 429–438, 1980.

    Article  PubMed  CAS  Google Scholar 

  60. Silver MS, Pollock J, Silver MD, et al: Calcification in porcine xenograft valves in children. Am J Cardiol 45: 685–689, 1980.

    Article  PubMed  CAS  Google Scholar 

  61. Gallueci V, Bortolotti U, Milano A, et al: Isolated mitral valve replacement with the Hancock bioprosthesis: a 13-year appraisal. Ann Thorac Surg 38: 571–577, 1984.

    Article  Google Scholar 

  62. Oyer PE, Miller DC, Stinson EB, et al: The performance of the Hancock bioprosthetic valve over an IIV2 year follow-up period: a perliminary report. In Duran C, Angell WW, Johnson AD, Oury JH (eds): Recent Progress in Mitral Heart Valve Disease. London: Butterworth, 1984, pp. 244–251.

    Google Scholar 

  63. Magilligan DJ Jr, Lewis JW Jr, Tilley B, Peterson E: The porcine bioprosthetic valve: twelve years later. J Thorac Cardiovasc Surg 89: 499–507, 1985.

    PubMed  Google Scholar 

  64. Gallo I, Nistal F, Artinano E: Six- to ten-year follow-up of patients with the Hancock cardiac bioprosthesis: incidence of primary tissue failure. J Thorac Cardiovasc Surg 92: 14–20, 1986.

    PubMed  CAS  Google Scholar 

  65. Foster AH, Greenberg GJ, Underhill DJ, et al: Intrinsic failure of Hancock mitral bio-prostheses: 10- to 15-year experience. Ann Thorac Surg 44: 568–577, 1987.

    Article  PubMed  CAS  Google Scholar 

  66. Brofman PR, Carvalho RG, Ribeiro EJ, et al: Dura mater bioprostheses in young patients. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 265–272.

    Google Scholar 

  67. Ferrans VJ, Boyce SW, Billingham ME, et al: Infection of glutaraldehyde-preserved porcine valve heterografts. Am J Cardiol 43: 1123–1136, 1979.

    Article  PubMed  CAS  Google Scholar 

  68. Ferrans VJ, IshiharaT, Jones M, et al: Pathogenesis and stages of bioprosthetic infection. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 346–361.

    Google Scholar 

  69. Levy RJ, Schoen FJ, Sherman FS, et al: Calcification of subcutaneously implanted type I collagen sponges. Am J Pathol 122: 71–82, 1986.

    PubMed  CAS  Google Scholar 

  70. Golomb G, Schoen FJ, Smith MS, et al: The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 127: 122–130, 1987.

    PubMed  CAS  Google Scholar 

  71. Harasake H, Nose Y, McMahon JT, et al: Calcification in blood pumps. In: Devices and Technology Branch Contractors Meeting 1987, Program. Bethesda: Division of Heart and Vascular Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, 1987.

    Google Scholar 

  72. Van Buskirk JJ, Kirsch WM, Kleyer DL, et al: Aminomalonie acid: identification in E. coli and atherosclerotic plaque. Proc Natl Acad Sci USA 81: 722–725, 1984.

    Article  PubMed  Google Scholar 

  73. Koch TH, Bohemier D, Wheelan P, et al: Aminomalonie acid and the calcification of protein. In: Devices and Technology Branch Contractors Meeting 1987, Program. Bethesda: Division of Heart and Vascular Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, 1987.

    Google Scholar 

  74. Lian JB, Skinner M, Glimcher MJ, Gallop P: The presence of 7-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun 73: 349–355, 1976.

    Article  PubMed  CAS  Google Scholar 

  75. Levy RJ, Schoen FJ, Levy JT, et al: Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 113: 143–155, 1983.

    PubMed  CAS  Google Scholar 

  76. Levy RJ, Zenker JA, Lian JB: Vitamin K-depen- dent calcium binding poteins in aortic valve calcification. J Clin Invest 65: 563–566, 1980.

    Article  PubMed  CAS  Google Scholar 

  77. Levy RJ, Zenker JA, Bernhard WF: Porcine bioprosthetic valve calcification in bovine left ventricle-aorta shunts: studies of the depositionof vitamin K-dependent proteins. Ann Thorac Surg 36: 187–192, 1983.

    Article  PubMed  CAS  Google Scholar 

  78. Bick RL: Anticoagulant and antiplatelet therapy. In Murano G, Bick RL (eds): Basic Concepts of Hemostasis and Thrombosis. Boca Raton: CRC Press, 1980, pp. 245–258.

    Google Scholar 

  79. Stein PD, Riddle JM, Kemp SR, et al: Effect of warfarin on calcification of spontaneously de-generated porcine bioprosthetic valves. J Thorac Cardiovasc Surg 90: 119–125, 1985.

    PubMed  CAS  Google Scholar 

  80. Carpentier A, Nashef A, Carpentier S, et al: Techniques for prevention of calcification of valvular bioprostheses. Circulation 70 (suppl I): I165–I168, 1984.

    Google Scholar 

  81. Lentz DJ, Pollock EM, Olsen DB, et al: Inhibition of mineralization of glutaraldehyde-fixed Hancock bioprosthetic heart valves. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 306–319.

    Google Scholar 

  82. Lentz DJ, Pollock EM, Olsen DB, et al: Inhibition of mineralization of glutaraldehyde-fixed Hancock bioprosthetic heart valves. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 306–319.

    Google Scholar 

  83. Dmitrovsky E, Boskey AL: Calcium-acidic phos- pholipid-phosphate complexes in human atherosclerotic aortas. Calcif Tissue Int 37: 121–125, 1985.

    Article  PubMed  CAS  Google Scholar 

  84. Gasser AB, Morgan DB, Fleisch HA, Richelle LJ: The influence of two diphosphonates on calcium metabolism in rats. Clin Sci 43: 31–45, 1972.

    PubMed  CAS  Google Scholar 

  85. Meyer JL, Nancollas GH: The influence of multidentate organic diphosphonates on crystal growth of hydroxy apatite. Calcif Tissue Res 13: 265–303, 1973.

    Article  Google Scholar 

  86. Lamson ML, Fox JL, Higuchi WJ: Calcium and 1-hydroxyethylidene-l, 1-diphosphonic acid: polynuclear complex formation in physiological range of pH. Int J Pharm 21: 143–154, 1966.

    Article  Google Scholar 

  87. Levy RJ, Hawley MA, Schoen FJ, et al: Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Circulation 71: 349–356, 1985.

    Article  PubMed  CAS  Google Scholar 

  88. Schoen FJ, Levy RJ: Pathophysiology of bio-prosthetic heart valve calcification. In: Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 418–441.

    Google Scholar 

  89. Levy RJ, Schoen FJ, Lund SA, Smith MS: Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy: experimental studies of optimal dosages and therapeutic durations. J Thorac Cardiovasc Surg 94: 551–557, 1987.

    PubMed  CAS  Google Scholar 

  90. Levy RJ, Wolfrum J, Schoen FJ, et al: Inhibition of calcification of bioprosthetic heart valves by local controlled release diphosphonate. Science 228: 190–192, 1985.

    Article  PubMed  CAS  Google Scholar 

  91. Golomb G, Langer R, Schoen FJ, et al: Controlled release diphosphonate to inhibit bioprosthetic heart valve calcification: dose response and mechanistic studies. J Contr Rel 4: 181–194, 1986.

    Article  CAS  Google Scholar 

  92. Levy RJ, Amidon G, Johnston T, Schoen FJ: Cardiovascular calcification: pathophysiology and treatment. In: Devices and Technology Branch Contractors Meeting, 1987. Program. Bethesda: Division of Heart and Vascular Diseases, National Heart, Lung and Blood Institutes, National Institutes of Health, Department of Health and Human Services, 1987, p. 142.

    Google Scholar 

  93. Urist MR, Adams JM: Effects of various blocking agents upon local mechanisms of calcification. Arch Pathol 81: 325–342, 1966.

    PubMed  CAS  Google Scholar 

  94. Carpentier A, Nashef A, Carpentier S, et al: Prevention of tissue valve calcification by chemical techniques. In: Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 320–327.

    Google Scholar 

  95. Menasche P, Hue A, Lavergne A, et al: Selective blockade of collagen-calcium binding sites: new process to decrease bioprosthetic valvular calcifi-cation. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 478–483.

    Google Scholar 

  96. Golomb G, Levy RJ: Prevention of calcification of glutaraldehyde-treated biomaterials by charge modification. Transactions of the Society for Biomaterials, 1987, p. 108.

    Google Scholar 

  97. Tsao JW, Schoen FJ, Shanker R, et al: Retardation of bovine pericardial bioprosthetic tissue calcification by a physiologic mineralization inhibitor, phosphoeitrate, administered locally. Transactions of the Society for Biomaterials, 1987, p. 144.

    Google Scholar 

  98. Schryer PJ, Tomasek FR, Starr JA, Wright JTM: Anticalcification effect of glutaraldehyde-pre- served valve tissue stored for increasing time in glutaraldehy de. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 471–477.

    Google Scholar 

  99. Koorajian S, Frugard G, Stegwell MJ: Sterilization of tissue valves. In Sebening F, Klovekorn WP, Meisner H, Struck E (eds): Bioprosthetic Cardiac Valves. Munich: Duetsches Herzzent-rum München, 1979, pp. 373–378.

    Google Scholar 

  100. Centers for Disease Control: Isolation of mycobacteria species from porcine heart valve prostheses. MMWR 26: 42–43, 1977.

    Google Scholar 

  101. Laskowski LF, Marr JJ, Spernoga JF, etal: Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N Engl J Med 297: 101–102, 1977.

    Article  PubMed  CAS  Google Scholar 

  102. Thubrikar MJ, Skinner JR, Eppink RT, Nolan SP: Stress analysis of porcine bioprosthetic heart valves in vivo. J Biomed Mater Res 16: 811–826, 1982.

    Article  PubMed  CAS  Google Scholar 

  103. Thubrikar M, Piegrass WC, Deck JD, Nolan SP: Stresses of natural versus prosthetic aortic valve leaflets in vivo. Ann Thorac Surg 30: 230–239, 1980.

    Article  PubMed  CAS  Google Scholar 

  104. Thubrikar M, Carabello BA, Aouad A, Nolan SP: Interpretation of aortic root angiography in dogs and humans. Cardiovasc Res 16: 16–21, 1982.

    Article  PubMed  CAS  Google Scholar 

  105. Thubrikar M, Piegrass, Bosher LP, Nolan SP: The elastic modulus of canine aortic valve leaflets in vivo and in vitro. Circ Res 47: 792–800, 1980.

    PubMed  CAS  Google Scholar 

  106. Van Steehoven AA, Veenstra PC, Reneman RS: The effect of some hemodynamic factors on the behavior of the aortic valve. J Biomech 15: 941–950, 1982.

    Article  Google Scholar 

  107. Van Steehoven AA, van Dongen MEH: The role of the trapped sinus vortex in aortic valve closure. In Schneck DJ (ed): Biofluid Mechanics 2. New York: Plenum, 1980, pp. 317–325.

    Google Scholar 

  108. Chong M, Eng M, Missirlis YF: Aortic valve mechanics. II. A stress analysis of porcine aortic valve leaflets in diastole. Biomater Med Devices Artif Organs 6: 225–244, 1978.

    PubMed  CAS  Google Scholar 

  109. Reis RL, Hancock WD, Yarbrough JW, et al: The flexible stent: a new eoncepl in the fabrication of tissue heart valve prostheses. J Thorac Cardiovasc 62: 683–689, 1971.

    CAS  Google Scholar 

  110. Thomson FJ, Barratt-Boyes BG: The glutaral- dehyde-treated heterograft valve. J Thorac Cardiovasc Surg 74: 317–321, 1977.

    PubMed  CAS  Google Scholar 

  111. Wright JTM, Eberhart CE, Gibbs ML, et al: Hancock II—an improved bioprosthesis. In Cohn LH, Gallucci V (eds): Cardiac Bioprostheses. New York: Yorke, 1982, pp. 425–444.

    Google Scholar 

  112. Carpentier AF, Lane E: Supported bioprosthetic heart valve with compliant orifice ring. US Patent 4,106, 129, 1978.

    Google Scholar 

  113. Borkon AM, Mcintosh CL, Jones M, et al: Inward stent-post bending of a porcine bioprosthesis in the mitral position: cause of bioprosthetic dysfunction. J Thorac Cardiovasc Surg 83: 105–107, 1982.

    PubMed  CAS  Google Scholar 

  114. Salomon NW, Copeland JG, Goldman S, Larson DF: Unusual complication of the Hancock porcine heterograft: strut compression in the aortic root. J Thorac Cardiovasc Surg 77: 294–296, 1979.

    PubMed  CAS  Google Scholar 

  115. Magilligan DJ, Fisher E, Alam M: Hemolytic anemia with porcine xenograft aortic and mitral valves. J Thorac Cardiovasc Surg 79: 628–631, 1980.

    PubMed  Google Scholar 

  116. Schoen FJ, Schulman LJ, Cohn LH: Quantitative anatomic analysis of “stent creep” of explanted Hancock standard porcine bioprostheses used for cardiac valve replacement. Am J Cardiol 56: 110–114, 1985.

    Article  PubMed  CAS  Google Scholar 

  117. Levine FH, Buckley MJ, Austen WG: Hemodynamic evaluation of the Hancock modified orifice bioprosthesis in the aortic position. Circulation 58 (suppl I): 33–35, 1978.

    Google Scholar 

  118. Carpentier A, Dubost C, Lane E, et al: Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg 83: 27–42, 1982.

    PubMed  CAS  Google Scholar 

  119. Wright JTM: Porcine or pericardial valves? Now and the future: design and engineering consider-ations. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 567–579.

    Google Scholar 

  120. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A: Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bio-prostheses: emphasis on progressive structural deterioration. Circulation 76: 618 - 627, 1987.

    Article  PubMed  CAS  Google Scholar 

  121. Wheatley DJ, Fisher J, Reece IJ, et al: Primary tissue failure in pericardial heart valves. J Thorac Cardiovasc Surg 94: 367–374, 1987.

    PubMed  CAS  Google Scholar 

  122. Walley VM, Keon WJ: Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg 93: 925–933, 1987.

    PubMed  CAS  Google Scholar 

  123. Gabbay S, Bortolotti U, Wasserman F, et al: Long-term follow-up of the Ionescu-Shiley mitral pericardial xenograft. J Thorac Caradiovasc Surg 88: 758–763, 1984.

    CAS  Google Scholar 

  124. Brais MP, Bedard JP, Goldstein W, et al: Ionescu-Shiley pericardial xenografts: follow-up to 6 years. Ann Thorac Surg 39: 105–111, 1985.

    Article  PubMed  CAS  Google Scholar 

  125. Reul GJ, Cooley DA, Duncan JM, et al: Valve failure with the Ionescu-Shiley bovine pericardial bioprosthesis: analysis of 2680 patients. J Vasc Surg 2: 192–203, 1985.

    PubMed  Google Scholar 

  126. Nistal F, Garcia-Satue E, Artinano E, et al: Comparative study of primary tissue valve failure between Ionescu-Shiley pericardial and Hancock porcine valves in the aortic position. Am J Cardiol 57: 161–164, 1986.

    Article  PubMed  CAS  Google Scholar 

  127. Cooley DA, Ott DA, Reul GJ, et al: Ionescu-Shiley bovine pericardial bioprostheses: clinical results in 2701 patients. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 177–198.

    Google Scholar 

  128. Bortolotti U, Milano A, Thiene G, et al: Early mechanical failures of the Hancock pericardial xenograft. J Thorac Cardiovasc Surg 94: 200–207, 1987.

    PubMed  CAS  Google Scholar 

  129. Yoganathan AP, Woo YR, Sung HW, et al: In vitro hemodynamic characteristics of tissue bioprostheses in the aortic position. J Thorac Cardiovasc Surg 92: 198–209, 1986.

    PubMed  CAS  Google Scholar 

  130. Yoganathan AP, Woo YR, Sung HW, et al: In vitro hemodynamic characteristics of tissue bioprostheses in the aortic position. J Thorac Cardiovasc Surg 92: 198–209, 1986.

    PubMed  CAS  Google Scholar 

  131. Heng MK, Baratt-Boyes BG, Agnew TM, et al: Isolated mitral replacement with stent- mounted antibiotic-treated aortic allograft valves. J Thorac Cardiovasc Surg 74: 230–235, 1977.

    PubMed  CAS  Google Scholar 

  132. Christie GW, Gavin JB, Barratt-Boyes BG: Graft detachment, a cause of incompetence in stent- mounted aortic valve allografts. J Thorac Cardiovasc Surg 90: 901–906, 1985.

    PubMed  CAS  Google Scholar 

  133. Murray G: Homologous aortic-valve-segment transplants as a surgical treatment for aortic and mitral insufficiency. Angiology 7: 466–471, 1956.

    Article  PubMed  CAS  Google Scholar 

  134. Barratt-Boyes BG: Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 19: 131–150, 1964.

    Article  PubMed  CAS  Google Scholar 

  135. Ross DN: Homograft replacement of the aortic valve. Lancet 2: 487, 1962.

    Article  PubMed  CAS  Google Scholar 

  136. Ross DN, Somerville J: Correction of pulmonary atresia with a homograft aortic valvç. Lancet 2: 1446–1447, 1966.

    Article  PubMed  CAS  Google Scholar 

  137. Foster JH, Collins AH, Jacobs JK, Scott HW Jr: Long term follow-up of homografts used in the treatment of coarctation of the aorta. J Cardiovasc Surg 6: 111–120, 1965.

    CAS  Google Scholar 

  138. Ross D, Yacoub M: Homograft replacement of the aortic valve: a critical review. Prog Cardiovasc Dis 11: 926–929, 1965.

    Google Scholar 

  139. Davies H, Lessof MH, Robert CI, Ross DN: Homograft replacement of the aortic valve. Lancet 1: 926–929, 1965.

    Article  PubMed  CAS  Google Scholar 

  140. Barratt-Boyes BG, Roche HG, Brandt PWT, et al: Aortic homograft valve replacement: a long- term follow-up of an initial series of 101 patients. Circulation 40: 763–775, 1969.

    Google Scholar 

  141. Barratt-Boyes BG, Roche AHG, Whitlock RML: Six year review of the results of freehand aortic replacement using an antibiotic sterilized homograft valve. Circulation 55: 353–361, 1977.

    PubMed  CAS  Google Scholar 

  142. Angell WW, Shumway NE, Kosek JC: A five year study of viable aortic valve homografts. J Thorac Cardiovasc Surg 64: 329–338, 1972.

    PubMed  CAS  Google Scholar 

  143. Angell WW, Shumway NE, Kosek JC: A five year study of viable aortic valve homografts. J Thorac Cardiovasc Surg 64: 329–338, 1972.

    PubMed  CAS  Google Scholar 

  144. Yacoub M, Kittle CF: Sterilization of valve homografts by antibiotic solution. Circulation 41(suppl II):II29–II31, 1970.

    Google Scholar 

  145. Wain WH, Pearce HM, Riddell RW, Ross DN: A re-evaluation of antibiotic sterilization of heart valve allografts. Thorax 32: 740–742, 1977.

    Article  PubMed  CAS  Google Scholar 

  146. Malm JP, Bowman FO Jr, Harris PD, Kovalik ATW: An evaluation of aortic homografts sterilized by electron geam energy. J Thorac Cardiovasc Surg 54: 471–477, 1967.

    PubMed  CAS  Google Scholar 

  147. Aparicio SR, Donnelly RJ, Dexter F, Watson DA: Light and electron microscopic studies on homograft and heterograft heart valves. J Pathol 115: 147–162, 1975.

    Article  PubMed  CAS  Google Scholar 

  148. Angell WW, Angell JD, Oury JH, et al: Long- term follow-up of viable frozen aortic homo- grafts: a viable homograft valve bank. J Thorac Cardiovasc Surg 93: 815–822, 1987.

    PubMed  CAS  Google Scholar 

  149. O’Brien MF, Strafford EG, Gardner MAH, et al: A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 94: 812–823, 1987.

    PubMed  Google Scholar 

  150. Bodnar E, Wain WH, Martelli V, Ross DN: Long term performance of 580 homograft and autograft valves used for aortic valve replacement. Thorac Cardiovasc Surg 27: 31–38, 1979.

    Article  PubMed  CAS  Google Scholar 

  151. Barratt-Boyes BG, Roche AHG, Subramanyan R, et al: Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted free-hand in the aortic position. Circulation 75: 768–777, 1987.

    Article  PubMed  CAS  Google Scholar 

  152. Wain WH, Greco R, Ingegneri A, et al: 15 Years’ experience with 615 homograft and autograft aortic valve replacements. Int J Artif Organs 3: 169–172, 1980.

    PubMed  CAS  Google Scholar 

  153. Harris PD, Kovalik AJW, Marks JA, Malm JP: Factors modifying aortic homograft structure and function. Surgery 63: 45–59, 1968.

    Google Scholar 

  154. Hudson REB: Pathology of human aortic valve homografts. Br Heart J 28: 291–301, 1966.

    Article  PubMed  CAS  Google Scholar 

  155. Smith JC: The pathology of human aortic valve homografts. Thorax 22: 114–138, 1967.

    Article  PubMed  CAS  Google Scholar 

  156. Roe FJC, Glendenning OM: The carcinogenicity of beta-propiolactone for mouse skin. Br J Cancer 10: 357–362, 1956.

    Article  PubMed  CAS  Google Scholar 

  157. Kolman A, Naslund M, Calleman CJ: Genotoxie effects of ethylene oxide and the relevance to human cancer. Carcinogenesis 7: 1245–1250, 1986.

    Article  PubMed  CAS  Google Scholar 

  158. Davies H, Missen GAK, Blandford G, et al: Homograft replacementclinical and pathologic study. Am J Cardiol 22: 195–217, 1968.

    Article  PubMed  CAS  Google Scholar 

  159. Barratt-Boyes BG: Long-term follow-up of aortic valve grafts. Br Heart J 33 (suppl): 60–65, 1971.

    Google Scholar 

  160. Ingegneri A, Wain WH, Martelli V, et al: An 11 year assessment of 93 flash frozen homograft valves in the aortic position. Thorac Cardiovasc Surg 27: 304–397, 1979.

    Article  PubMed  CAS  Google Scholar 

  161. Livi U, Abdel-Kadir A, Parker R, et al: Viability and morphology of aortic and pulmonary homografts: a comparative study. J Thorac Cardiovasc Surg 93: 755–760, 1987.

    PubMed  CAS  Google Scholar 

  162. Pate JW, Sawyer PN: Freeze dried aortic grafts: a preliminary report of experimental evaluation. Am J Surg 86: 3–13, 1953.

    Article  PubMed  CAS  Google Scholar 

  163. Reichenbach DD, Mohri H, Merendino KA: Pathological changes in human aortic valve ho- mografts. Circulation 39 (suppl I): I47–I56, 1969.

    Google Scholar 

  164. Brock RC: Long-term degenerative changes in aortic segment homografts with particular reference to calcification. Thorax 23: 249–255, 1968.

    Article  PubMed  CAS  Google Scholar 

  165. Knaghani A, Dhalla N, Penta A, et al: Patient status 10 years or more after aortic valve replacement using antibiotic sterilized homografts. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 38–46.

    Google Scholar 

  166. Ferrans VJ, Hilbert SL, Tornita Y, et al: Mor-phology of collagen in bioprosthetic heart valves. In Nimni M (ed): Collagen, Vol. 3: Biotechnology. Boca Raton: CRC Press, 1988, pp. 145–189.

    Google Scholar 

  167. Polystan Bioprostheses Information Bulletins BP A, BPC, BPD, BPE, BPF, and BP1. Copenhagen: Polystan A/S, 1980.

    Google Scholar 

  168. Ishihara T, Ferrans VJ, Jones M, et al: Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardial valvular bioprostheses. J Thorac Cardiovasc Surg 81: 747–757, 1981.

    PubMed  CAS  Google Scholar 

  169. Ferrans VJ, Thiedemann KU: Ultrastructure of the normal heart. In Silver MD (ed): Cardiovascular Pathology. New York: Churchill Livingstone, 1983, pp. 31–86.

    Google Scholar 

  170. Gross L, Kugel MA: Topographic anatomy and histology of the valves in the human heart. Am J Pathol 7: 445–473, 1931.

    PubMed  CAS  Google Scholar 

  171. Sell S, Scully RE: Aging changes in the aortic and mitral valves: histologic and histoehemical studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus. Am J Pathol 46: 345–365, 1965.

    PubMed  CAS  Google Scholar 

  172. Khanna SK, Ross JK, Monro JL: Homograft aortic valve replacement: seven years’ experience with antibiotic-treated valves. Thorax 36: 330–337, 1981.

    Article  PubMed  CAS  Google Scholar 

  173. Ross DN, Martelli V, Wain WH: Allograft and antograft valves used for aortic valve replacement. In Ionescu MJ (ed): Tissue Heart Valves. London: Butterworth, 1979, pp. 127–172.

    Google Scholar 

  174. Kay PH, Ross DN: Fifteen years’ experience with the aortic homograft: the conduit of choice for right ventricular outflow tract reconstruction. Ann Thorac Surg 40: 360–363, 1985.

    Article  PubMed  CAS  Google Scholar 

  175. Shabbo FP, Wain WH, Ross DN: Right ventricular outflow reconstruction with aortic homograft conduit: analysis of long-term results. Thorac Cadiovasc Surg 28: 21–25, 1980.

    Article  CAS  Google Scholar 

  176. Fontan F, Choussat A, Peville C, et al: Aortic valve homografts in the surgical treatment of complex cardiac malformations. J Thorac Car-diovasc Surg 87: 649–657, 1984.

    CAS  Google Scholar 

  177. Jonas RA, Freed MD, Mayer JF, Castaneda AR: Long-term follow-up of patients with synthetic right heart conduits. Circulation 72(suppl II):II77–II83, 1985.

    Google Scholar 

  178. Miller DC, Stinson ES, Oyer PE, et al: Durability of porcine xenograft valves and conduits in children. Circulation 66 (suppl I): 172–185, 1982.

    Google Scholar 

  179. Ferrans VJ, Arbustini E, Eido EE, Jones M: Anatomic changes in right ventricular-pulmonary artery conduits implanted in baboons. In Bodnar E, Yacoub M (eds): Biologic and Bioprosthetic Valves. New York: Yorke, 1986, pp. 316–339.

    Google Scholar 

  180. Robbins SL: Cell injury and cell death. In: Pathologic Basis of Disease. Philadelphia: Saun-ders, 1974, pp. 21 - 54.

    Google Scholar 

  181. Armiger LC, Thomson RW, Strickett MG, Barratt-Boyes BG: Morphology of heart valves preserved by liquid nitrogen freezing. Thorax 40: 778–786, 1985.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Stephen L. Hilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor J. Ferrans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Hilbert, S.L., Ferrans, V.J., Jones, M. (1989). Effects of Preimplantation Processing on Bioprosthetic and Biologic Cardiac Valve Morphology. In: Cardiac Reconstructions with Allograft Valves. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3568-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3568-2_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-8159-7

  • Online ISBN: 978-1-4612-3568-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation